Doinseunggitang Ameliorates Endothelial Dysfunction in Diabetic Atherosclerosis

Abstract EN

Atherosclerosis, a chronic and progressive disease characterized by vascular inflammation, is a leading cause of death in diabetes patients.

Doinseunggitang (DYSGT), traditional prescription, has been used for promoting blood circulation to remove blood stasis.

The aim of this study was to investigate the beneficial effects of DYSGT on endothelial dysfunction in diabetic atherosclerosis animal model.

Apolipoprotein E knockout (ApoE KO) mice fed on a Western diet were treated with DYSGT (200 mg/kg/day).

DYSGT significantly lowered blood glucose level and glucose tolerance as well as systolic blood pressure.

Metabolic parameter showed that DYSGT markedly decreased triglyceride and LDL-cholesterol levels.

In the thoracic aorta, the impairment of vasorelaxation response to acetylcholine and atherosclerotic lesion was attenuated by DYSGT.

Furthermore, DYSGT restored the reduction of endothelial nitric oxide synthase (eNOS) expression, leading to the inhibition of intracellular adhesion molecule-1 (ICAM-1) and endothelin-1 (ET-1) expression.

In conclusion, DYSGT improved the development of diabetic atherosclerosis via attenuation of the endothelial dysfunction, possibly by inhibiting ET-1, cell adhesion molecules, and lesion formation.

Therefore, these results suggest that Korean traditional prescription Doinseunggitang may be useful in the treatment and prevention of diabetic vascular complications.